119 related articles for article (PubMed ID: 29084518)
1. No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis.
Qi XL; Yao J; Zhang Y
BMC Med Genet; 2017 Oct; 18(1):123. PubMed ID: 29084518
[TBL] [Abstract][Full Text] [Related]
2. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
3. Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.
Chaudhary S; Panda AK; Mishra DR; Mishra SK
PLoS One; 2013; 8(1):e53308. PubMed ID: 23349706
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.
Liu T; Chen L; Sun X; Wang Y; Li S; Yin X; Wang X; Ding C; Li H; Di W
Tumour Biol; 2014 Mar; 35(3):2427-36. PubMed ID: 24197980
[TBL] [Abstract][Full Text] [Related]
5. GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.
Huggins GS; Wong JY; Hankinson SE; De Vivo I
Cancer Res; 2006 Feb; 66(3):1384-90. PubMed ID: 16452193
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
[TBL] [Abstract][Full Text] [Related]
7. Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk.
Vang A; Salem K; Fowler AM
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36702635
[TBL] [Abstract][Full Text] [Related]
8. Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial cancer in Caucasian women: a meta-analysis.
Pabalan N; Pineda MR; Jarjanazi H; Christofolini DM; Barbosa CP; Bianco B
Arch Gynecol Obstet; 2015 Jan; 291(1):115-22. PubMed ID: 25037596
[TBL] [Abstract][Full Text] [Related]
9. +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.
Kotsopoulos J; Tworoger SS; De Vivo I; Hankinson SE; Hunter DJ; Willett WC; Chen WY
Int J Cancer; 2009 Oct; 125(7):1685-91. PubMed ID: 19462450
[TBL] [Abstract][Full Text] [Related]
10. No association between the progesterone receptor gene +331G/A polymorphism and breast cancer.
Feigelson HS; Rodriguez C; Jacobs EJ; Diver WR; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1084-5. PubMed ID: 15184270
[No Abstract] [Full Text] [Related]
11. Polymorphisms of progesterone receptor and ovarian cancer risk: a systemic review and meta-analysis.
Liao J; Ding D; Sun C; Weng D; Meng L; Chen G; Ma D
J Obstet Gynaecol Res; 2015 Feb; 41(2):178-87. PubMed ID: 25228088
[TBL] [Abstract][Full Text] [Related]
12. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
[TBL] [Abstract][Full Text] [Related]
13. Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.
Ghali RM; Al-Mutawa MA; Ebrahim BH; Jrah HH; Zaied S; Bhiri H; Hmila F; Mahjoub T; Almawi WY
Pathol Oncol Res; 2020 Jan; 26(1):141-147. PubMed ID: 29302853
[TBL] [Abstract][Full Text] [Related]
14. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
[TBL] [Abstract][Full Text] [Related]
15. Associations between C1772T polymorphism in hypoxia-inducible factor-1α gene and breast cancer: a meta-analysis.
Ren HT; Wang XJ; Kang HF; Lin S; Wang M; Dai ZJ
Med Sci Monit; 2014 Dec; 20():2578-83. PubMed ID: 25484025
[TBL] [Abstract][Full Text] [Related]
16. Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.
Chen Q; Shi R; Liu W; Jiang D
PLoS One; 2013; 8(8):e72487. PubMed ID: 23977306
[TBL] [Abstract][Full Text] [Related]
17. Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
Yang DS; Sung HJ; Woo OH; Park KH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
Cancer Genet Cytogenet; 2010 Jan; 196(2):194-7. PubMed ID: 20082859
[TBL] [Abstract][Full Text] [Related]
18. The Alu-insertion progesterone receptor gene polymorphism is not associated with breast cancer: a meta-analysis.
Yao J; Qi XL; Zhang Y
BMC Med Genet; 2018 Jan; 19(1):16. PubMed ID: 29370776
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study.
Kanabekova P; Al-Awadi AM; Bauyrzhanova Z; Tahtouh T; Sarray S; Almawi WY
Gene; 2022 Apr; 820():146288. PubMed ID: 35143942
[TBL] [Abstract][Full Text] [Related]
20. Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.
Chen W; Yang H; Tang WR; Feng SJ; Wei YL
Asian Pac J Cancer Prev; 2014; 15(22):9643-7. PubMed ID: 25520082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
